LINC00675 is a Prognostic Factor and Regulates Cell Proliferation, Migration and Invasion in Glioma
Overview
Authors
Affiliations
LINC00675 has been suggested to be dysregulated in gastric cancer, colorectal cancer and pancreatic cancer. However, the expression status and biological function of LINC00675 in glioma were still unknown. Thus, we reported LINC00675 was overexpressed in glioma tissues and cell lines, and positively associated with advanced WHO grade, large tumor size and poor prognosis. Moreover, univariate and multivariate analyses suggested that high-expression of LINC00675 was an independent unfavorable prognostic predictor for glioma. In addition, levels of LINC00675 expression were positively correlated with TRIP6 mRNA and protein expressions. The experiment showed that silencing of LINC00675 inhibits glioma cell proliferation, migration and invasion through regulating TRIP6. In conclusion, LINC00675 acts as a tumor promoter in glioma progression.
Liu X, Chen Y, Wan H, Wang Y, Wang Y, Gao Y Sci Rep. 2024; 14(1):4042.
PMID: 38369589 PMC: 10874967. DOI: 10.1038/s41598-024-54670-0.
Miao M, Li M, Liu Z, Yang W, Wang C, Hu R Transl Cancer Res. 2022; 9(11):6867-6880.
PMID: 35117295 PMC: 8798533. DOI: 10.21037/tcr-20-1714.
Functional Peptides Encoded by Long Non-Coding RNAs in Gastrointestinal Cancer.
Chen Y, Long W, Yang L, Zhao Y, Wu X, Li M Front Oncol. 2021; 11:777374.
PMID: 34888249 PMC: 8649637. DOI: 10.3389/fonc.2021.777374.
Fan S, Wang L Bioengineered. 2021; 12(2):10690-10702.
PMID: 34738869 PMC: 8810037. DOI: 10.1080/21655979.2021.2001905.
Lu L, Li S, Zhang Y, Luo Z, Chen Y, Ma J Front Oncol. 2021; 10:607593.
PMID: 33489916 PMC: 7820889. DOI: 10.3389/fonc.2020.607593.